Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant

Abstract

In patients with noninfectious posterior uveitis, sustained-release dexamethasone 0.7 mg intravitreal implant may be an effective treatment option for controlling intraocular inflammation.